310 related articles for article (PubMed ID: 27624963)
41. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
Qiao W; Ji S; Zhao Y; Hu T
Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319
[TBL] [Abstract][Full Text] [Related]
42. Gradual solubilization of Candida cell wall beta-glucan by oxidative degradation in mice.
Miura NN; Miura T; Ohno N; Adachi Y; Watanabe M; Tamura H; Tanaka S; Yadomae T
FEMS Immunol Med Microbiol; 1998 Jun; 21(2):123-9. PubMed ID: 9685001
[TBL] [Abstract][Full Text] [Related]
43. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
Han Y; Ulrich MA; Cutler JE
J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
[TBL] [Abstract][Full Text] [Related]
44. IgG to various beta-glucans in a human adult population.
Noss I; Wouters IM; Smit LA; Meijer E; Pronk A; Heederik DJ; Doekes G
Int Arch Allergy Immunol; 2012; 157(1):98-108. PubMed ID: 21912179
[TBL] [Abstract][Full Text] [Related]
45. Immune cell response to Candida cell wall mannan derived branched α-oligomannoside conjugates in mice.
Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
J Microbiol Immunol Infect; 2015 Feb; 48(1):9-19. PubMed ID: 24239417
[TBL] [Abstract][Full Text] [Related]
46. Solubilized cell wall beta-glucan, CSBG, is an epitope of Candida immune mice.
Uchiyama M; Ohno N; Miura NN; Adachi Y; Tamura H; Tanaka S; Yadomae T
Biol Pharm Bull; 2000 May; 23(5):672-6. PubMed ID: 10823689
[TBL] [Abstract][Full Text] [Related]
47. Vaccines in the treatment of invasive candidiasis.
Wang XJ; Sui X; Yan L; Wang Y; Cao YB; Jiang YY
Virulence; 2015; 6(4):309-15. PubMed ID: 25559739
[TBL] [Abstract][Full Text] [Related]
48. Role of anti-beta-glucan antibody in host defense against fungi.
Ishibashi K; Yoshida M; Nakabayashi I; Shinohara H; Miura NN; Adachi Y; Ohno N
FEMS Immunol Med Microbiol; 2005 Apr; 44(1):99-109. PubMed ID: 15780582
[TBL] [Abstract][Full Text] [Related]
49. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
Xin H; Cutler JE
Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of antifungal vaccines by conjugation of β-1,2 trimannosides with T-cell peptides and covalent anchoring of neoglycopeptide to tetanus toxoid.
Cartmell J; Paszkiewicz E; Dziadek S; Tam PH; Luu T; Sarkar S; Lipinski T; Bundle DR
Carbohydr Res; 2015 Feb; 403():123-34. PubMed ID: 25126994
[TBL] [Abstract][Full Text] [Related]
51. Integrin Cross-Talk Regulates the Human Neutrophil Response to Fungal β-Glucan in the Context of the Extracellular Matrix: A Prominent Role for VLA3 in the Antifungal Response.
Johnson CM; O'Brien XM; Byrd AS; Parisi VE; Loosely AJ; Li W; Witt H; Faridi MH; LeFort CT; Gupta V; Kim M; Reichner JS
J Immunol; 2017 Jan; 198(1):318-334. PubMed ID: 27852744
[TBL] [Abstract][Full Text] [Related]
52. In silico Design of a Multivalent Vaccine Against Candida albicans.
Tarang S; Kesherwani V; LaTendresse B; Lindgren L; Rocha-Sanchez SM; Weston MD
Sci Rep; 2020 Jan; 10(1):1066. PubMed ID: 31974431
[TBL] [Abstract][Full Text] [Related]
53. Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate.
Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
Int Immunopharmacol; 2012 Oct; 14(2):179-87. PubMed ID: 22835427
[TBL] [Abstract][Full Text] [Related]
54. Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.
Bundle DR; Nycholat C; Costello C; Rennie R; Lipinski T
ACS Chem Biol; 2012 Oct; 7(10):1754-63. PubMed ID: 22877569
[TBL] [Abstract][Full Text] [Related]
55. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.
Adams EL; Rice PJ; Graves B; Ensley HE; Yu H; Brown GD; Gordon S; Monteiro MA; Papp-Szabo E; Lowman DW; Power TD; Wempe MF; Williams DL
J Pharmacol Exp Ther; 2008 Apr; 325(1):115-23. PubMed ID: 18171906
[TBL] [Abstract][Full Text] [Related]
56. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis.
Thomas DP; Viudes A; Monteagudo C; Lazzell AL; Saville SP; López-Ribot JL
Proteomics; 2006 Nov; 6(22):6033-41. PubMed ID: 17051645
[TBL] [Abstract][Full Text] [Related]
57. Measurement of (1-->3)-beta-D-glucan in an experimental model of systemic candidiasis.
Kawagoe T; Nakao A; Kanbe T; Tamura H; Tanaka S; Takagi H
Eur Surg Res; 1998; 30(4):290-6. PubMed ID: 9704756
[TBL] [Abstract][Full Text] [Related]
58. beta-Glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells.
Nisini R; Torosantucci A; Romagnoli G; Chiani P; Donati S; Gagliardi MC; Teloni R; Sargentini V; Mariotti S; Iorio E; Cassone A
J Leukoc Biol; 2007 Nov; 82(5):1136-42. PubMed ID: 17656653
[TBL] [Abstract][Full Text] [Related]
59. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F
Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974
[TBL] [Abstract][Full Text] [Related]
60. β-1,3-Glucan/CR3/SYK pathway-dependent LC3B-II accumulation enhanced the fungicidal activity in human neutrophils.
Li D; Bai C; Zhang Q; Li Z; Shao D; Li X
J Microbiol; 2019 Apr; 57(4):263-270. PubMed ID: 30721460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
